Dr. Raymon H. Grogan is currently Chief of Endocrine Surgery at Baylor College of Medicine in Houston, Texas. He is an accomplished author of several surgical journal manuscripts and book chapters, he has authored and edited a book on Endocrine Surgery and, has helped co-author several national guidelines in the area of endocrine surgery. In addition to having expertise in the traditional surgical approaches to the thyroid, parathyroid, and adrenal glands, Dr. Grogan is one of only a few experts in the United States on Transoral Endocrine Surgery, a novel approach to surgery for both thyroid and parathyroid disease that leaves no visible scar. He is one of the first surgeons to perform this operation in the United States, and has both proctored the operation and been invited to speak on the operation at hospitals and conferences around the world.
In addition to being a full-time clinical surgeon, Dr. Grogan also runs a successful translational research program. He has a Master’s of Science with a focus on epidemiology and biostatistics. He is the Principal Investigator and founder of the North American Thyroid Cancer Survivorship Study, which is a longitudinal cohort study that currently has nearly 3,000 participants enrolled and continues to expand. Through this work Dr. Grogan has published several novel findings related to thyroid cancer survivorship and has helped start a national discussion on ways to improve quality of life in these patients. In addition to this Dr. Grogan has published several papers on health outcomes related to endocrine surgery as well as translational papers on the genetics and epidemiology of endocrine diseases. Most recently Dr. Grogan has begun research on the relationship between the human microbiome and thyroid disease. In 2017 he was awarded the prestigious Paul LoGerfo Research Grant from the American Association of Endocrine Surgeons to study this relationship.